BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2452469)

  • 1. Biochemical and immunologic diagnosis of cancer. Pancreatic and gastric cancer.
    Burtin P
    Tumour Biol; 1987; 8(2-3):84-5. PubMed ID: 2452469
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical and immunologic diagnosis of cancer. Colorectal cancer.
    von Kleist S
    Tumour Biol; 1987; 8(2-3):78-83. PubMed ID: 3329404
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical value of CA 19-9 (carbohydrate antigen) in gastrointestinal adenocarcinoma.
    Mennini G; Silecchia G; Zanna C; Cucchiara G; Spadaro G; Greco E; Basoli A; Speranza V
    Ital J Surg Sci; 1985; 15(1):37-43. PubMed ID: 3858272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor markers in the upper intestinal tract--stomach and pancreas].
    Pointner R; Conrad F; Schwab G
    Wien Klin Wochenschr; 1989 Jul; 101(14):482-4. PubMed ID: 2773485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Improving the diagnostic efficacy of carcinoembryonic antigen (CEA) in gastric cancer by the simultaneous administration of Ca 72.4].
    Sagredo E; Soriano A; Vivanco FJ; Ruibal A
    Rev Clin Esp; 1989 Apr; 184(6):336-7. PubMed ID: 2756226
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic markers of pancreatic cancer in humans].
    Kulagin PP; Chalov VV
    Vopr Onkol; 1983; 29(8):62-7. PubMed ID: 6193639
    [No Abstract]   [Full Text] [Related]  

  • 7. Levels of carcinoembryonic antigen (CEA) and carbohydrate antigen (CA 19-9) in sera and pancreatic juice in the diagnosis of pancreatic cancer.
    Lin JT; Wang TH; Chen DS; Sung JL
    Taiwan Yi Xue Hui Za Zhi; 1987 Aug; 86(8):823-8. PubMed ID: 3479516
    [No Abstract]   [Full Text] [Related]  

  • 8. [Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].
    Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):101-8. PubMed ID: 3455804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carcinoembryonic antigen, Ca 19-9 and Ca 125 antigen levels in the sera of patients with cancer of the stomach].
    Bukowski J; Góźdź S; Słuszniak J; Słuszniak A; Korejba W; Zieliński A; Banasińska E
    Pol Tyg Lek; 1988 Feb; 43(5):136-9. PubMed ID: 3165528
    [No Abstract]   [Full Text] [Related]  

  • 10. [Occurrence of pancreatic tumor markers and diagnosis of small pancreatic tumors. 7). Usefulness of combination assay].
    Niitsu Y; Kohda K
    Nihon Rinsho; 1986 Aug; 44(8):1843-7. PubMed ID: 3537376
    [No Abstract]   [Full Text] [Related]  

  • 11. [CA-19-9, CA50 and CEA in pancreatic and gastrointestinal tumors. Comparative studies].
    Dienst C; Clodius T; Oldörp T; Uhlenbruck G; Diehl V
    Med Klin (Munich); 1987 Jan; 82(2):45-50. PubMed ID: 3470595
    [No Abstract]   [Full Text] [Related]  

  • 12. [A promising tumor marker CA 19-9 for pancreatic carcinoma: comparison with CEA and elastase 1].
    Sakahara H; Endo K; Nakajima K; Nakashima T; Ohta H; Torizuka K; Naito A; Suzuki T
    Kaku Igaku; 1985 Jan; 22(1):115-8. PubMed ID: 3858565
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
    Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
    Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fundamental and clinical evaluation of IRMA for serum SPan-1 antigen].
    Fukuda Y; Murakami M; Fukuchi M
    Kaku Igaku; 1990 Apr; 27(4):405-13. PubMed ID: 2165543
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnosis of pancreatic neoplasms by analysis of tumor markers and pancreatic enzymes].
    Ochi K
    Nihon Naika Gakkai Zasshi; 1992 Dec; 81(12):1951-4. PubMed ID: 1283865
    [No Abstract]   [Full Text] [Related]  

  • 16. Specificity of carcinoembryonic antigen, gastrointestinal cancer-associated antigen, tissue polypeptide antigen, fibrinopeptide A and gamma-glutamyltransferase in the diagnosis and follow-up of gastric cancer.
    Abbasciano V; Levato F; Zavagli G
    Oncology; 1988; 45(3):159-61. PubMed ID: 2897101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum pancreatic enzymes and enzyme inhibitor as a tumor marker for pancreatic cancer].
    Ogawa M
    Rinsho Byori; 1986 Nov; 34(11):1229-35. PubMed ID: 2434691
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of serum pancreatic enzymes, carbohydrate antigen 19-9, and carcinoembryonic antigen in various pancreatic diseases.
    Satake K; Kanazawa G; Kho I; Chung Y; Umeyama K
    Am J Gastroenterol; 1985 Aug; 80(8):630-6. PubMed ID: 2411125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combined use of CA 19-9 and carcino-embryonic antigen (CEA) in malignancies of the gastrointestinal tract.
    Staab HJ
    Acta Gastroenterol Belg; 1987; 50(1):29-35. PubMed ID: 3480668
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tumor markers in the diagnosis of pancreatic carcinoma].
    Lemma F; Bombardieri T; Salibra M; Trovato P; De Pasquale MC; Faraone V; Punturiero R; Di Mauro S
    Minerva Med; 1989 Jul; 80(7):645-9. PubMed ID: 2779818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.